Cargando…
MDMA targets miR-124/MEKK3 via MALAT1 to promote Parkinson’s disease progression
BACKGROUND: Parkinson’s disease (PD) is a well-known neurodegenerative disease that is usually caused by the progressive loss of dopamine neurons and the formation of Lewy vesicles. 3,4-Methylenedioxymethamphetamine (MDMA) has been reported to cause damage to human substantia nigra neurons and an in...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635915/ https://www.ncbi.nlm.nih.gov/pubmed/37688681 http://dx.doi.org/10.1007/s11033-023-08775-w |